Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Merck
Moodys
Boehringer Ingelheim
Mallinckrodt
Harvard Business School
McKinsey

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Litigation Details for Pozen Inc. v. Par Pharmaceutical, Inc. (E.D. Tex. 2008)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Pozen Inc. v. Par Pharmaceutical, Inc. (E.D. Tex. 2008)

Docket   Start Trial Date Filed 2008-11-14
Court District Court, E.D. Texas Date Terminated 2011-08-05
Cause 35:271 Patent Infringement Assigned To Leonard E. Davis
Jury Demand None Referred To John D. Love
Parties ALPHAPHARM PTY LTD.; DR. REDDY'S LABORATORIES, INC.; GLAXO GROUP LTD. D/B/A GLAXOSMITHKLINE; PAR PHARMACEUTICAL, INC.; POZEN INC.; ROBERT W FAULKNER; ROY W HARDIN; SMITHKLINE BEECHAM CORP. D/B/A GLAXOSMITHKLINE; TEVA PHARMACEUTICALS USA INC.
Patents 5,872,145; 6,060,499; 6,586,458; 7,332,183
Attorneys Alexandra Olson; Allen Franklin Gardner; Amy Schoenhard; Aziz Burgy; Charles Ainsworth; Claude Edward Welch; Colleen Tracy; Collin Michael Maloney; Daniel Lee Tobey; Deron R Dacus; Erin A Thomson; Ha Kung Wong; Janine A Carlan; Jason E Johnson; Jeffer Ali; Joshua T Morris; Lindsay Hersh; M Jeffer Ali; Mark Schuman; Michael E Jones; Michael H Teschner; Natalie Clayton; Otis W Carroll , Jr; Paul H Kochanski; Rebecca Cantor; Rebecca J Cantor; Reese McKnight; Richard J Berman; Robert W Faulkner; Roy William Hardin; Samuel C Cohen; Samuel T Lockner; Scott K Reed; Stephanie Lollo; Stephen J Brown; Stephen M. Hash; Taniel Anderson; Thomas J Parker; Timothy W Bucknell; Tracey B Davies; Willem G Schuurman; William L Mentlik
Firms Fitzpatrick Cella Harper & Scinto - New York; JAMS Inc; Locke Lord Bissell & Liddell LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Pozen Inc. v. Par Pharmaceutical, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Pozen Inc. v. Par Pharmaceutical, Inc. (E.D. Tex. 2008)

Date Filed Document No. Description Snippet Link To Document
2010-01-29 172 Judgment of Indefiniteness of U.S. Patent No. 6,060,499 and 6,586,458 Under 35 USC Sec. 112 Para. 2 by …2008 5 August 2011 6:08-cv-00437 830 Patent None District Court, E.D. Texas External link to document
2010-02-12 177 Judgment of Indefiniteness of U.S. Patent No. 6,060,499 and 6,586,458 Under 35 USC Sec. 112 Para. 2 filed…2008 5 August 2011 6:08-cv-00437 830 Patent None District Court, E.D. Texas External link to document
2010-02-18 179 Judgment of Indefiniteness of U.S. Patent No. 6,060,499 and 6,586,458 Under 35 USC Sec. 112 Para. 2 filed…2008 5 August 2011 6:08-cv-00437 830 Patent None District Court, E.D. Texas External link to document
2010-06-18 257 the patents asserted by Plaintiff Pozen Inc. (“Pozen”). Pozen asserts U.S. Patent Nos. 6,060,499 (“the… U.S. PATENT Nos. 6,060,499, 6,586,458, and 7,332,183 …the ‘499 patent”), 6,586,458 (“the ‘458 patent”), and 7,332,183 (“the ‘183 patent”) and has filed an …of said agonist. ‘458 patent at 12:6–25 (claim 1). The ‘183 patent discloses a unique tablet…183 patent for the delivery of sumatriptan and naproxen. OPENING at 5. Claim 1 of the ‘183 patent is External link to document
2010-06-24 259 Summary Judgment of Indefiniteness of U.S. Patent No. 6,060,499 and 6,586,458 Under 35 USC Sec. 112 Para…2008 5 August 2011 6:08-cv-00437 830 Patent None District Court, E.D. Texas External link to document
2010-07-27 275 SEALED PATENT MOTION for Partial Summary Judgment of Noninfringement as to US Patent No. 7,332,183; Responses…2008 5 August 2011 6:08-cv-00437 830 Patent None District Court, E.D. Texas External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Merck
McKesson
Dow
McKinsey
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.